Monday, April 22, 2024

Merck shares rise on FDA approval for Winrevair

Must read



Merck shares gained 3.8% in after-hours trading Tuesday following approval of its new drug for a potentially fatal lung disease.



Source link

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article